Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer release label changed from v3.7.2 to v3.8.0, with no change to the clinical trial record content.
    Difference
    0.0%
    Check dated 2026-11-01T15:52:50.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A sitewide NIH notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence,” with both terms appearing during the transition.
    Difference
    0.2%
    Check dated 2026-10-25T16:25:14.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The website’s footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-18T22:09:07.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-11T22:23:20.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The revision history now shows a new revision entry for v3.7.0 and removes the previous v3.6.6, reflecting an update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-09-20T22:35:22.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    History now shows a new entry Revision: v3.6.6. The previous entry Revision: v3.6.5 has been removed.
    Difference
    0.0%
    Check dated 2026-08-30T21:53:35.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.